ADC Therapeutics Newsroom

Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development

BusinesswireDec 16 18:00

Transcenta Debuts Promising Anti-Tumor Activity of Novel LIV-1 Targeting ADCs With Site-Specific Conjugated Topo I Inhibitor Payload in TNBC Tumor Models at 2024 SABCS

PR NewswireDec 13 08:00

ADC Therapeutics Price Target Maintained With a $10.00/Share by Guggenheim

Dow JonesDec 12 23:40 · Ratings

ADC Therapeutics Analyst Ratings

BenzingaDec 12 01:59 · Ratings

ADC Therapeutics Shares Drop After Trial Results

InvestingDec 12 00:06

H.C. Wainwright Maintains ADC Therapeutics(ADCT.US) With Buy Rating, Maintains Target Price $8

Futu NewsDec 11 23:31 · Ratings

Promising Efficacy in LOTIS-7 Trial Boosts Buy Rating for ADC Therapeutics

TipRanksDec 11 23:25 · Ratings

Express News | ADC Therapeutics SA - No Dose-Limiting Toxicities or High-Grade Crs/Icans Observed

BreakingsDec 11 20:30

Express News | ADC Therapeutics SA - Zynlonta Plus Glofitamab Shows 94% Orr and 72% Cr Rate

BreakingsDec 11 20:30

ADC Therapeutics Announces Positive Initial Data From LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination With Bispecific Antibody in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

PR NewswireDec 11 20:30

ADC Therapeutics ADCT +63% Presentation; CERo CERO -40% New CEO

BioPharmCatalystDec 7 06:21

Top Midday Gainers

MT NewswiresDec 7 02:56

Express News | ADC Therapeutics to Provide Initial Data Update on Lotis-7 Clinical Trial

BreakingsDec 6 20:30

ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial

PR NewswireDec 6 20:30

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

PR NewswireDec 3 05:30

Investors Don't See Light At End Of ADC Therapeutics SA's (NYSE:ADCT) Tunnel And Push Stock Down 31%

Simply Wall StNov 19 18:05

ADC Therapeutics SA's (NYSE:ADCT) Institutional Investors Lost 18% Over the Past Week but Have Profited From Longer-term Gains

Simply Wall StNov 16 21:21

ADC Therapeutics SA (ADCT) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 10 00:16 · Conference Call

ADC Therapeutics SA (ADCT) Q3 2024 Earnings Call Transcript

Earnings Call TranscriptsNov 10 00:01

ADC Therapeutics Third Quarter 2024 Earnings: EPS Misses Expectations

Yahoo FinanceNov 9 22:14